This page lists all known medications that could potentially lead to 'Aggravated Angina Pectoris' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
The most recent data comes from the Efficacy of Ranolazine in Chronic Angina (ERICA) trial, published in the August 1, 2006, issue of JACC. 17 Stable patients with coronary disease and ≥3 anginal ...
Angina pectoris is a debilitating indication of thepresence of ischemic heart disease that affects millionsof Americans. Although a number of pharmacologictreatments are available, the annual numberof ...
Chronic angina is a major medical problem in the United States with more than 6 million patients affected, a number that will increase substantially because of the progressive aging of the population.
Add Yahoo as a preferred source to see more of our stories on Google. If angina pectoris – pain, pressure or tightness and shortness of breath – suddenly occurs even at rest, this can indicate an ...
BECAUSE angina pectoris is a consequence of inadequate myocardial oxygenation, ideal therapy for this incapacitating symptom would be directed toward both increasing coronary blood flow and decreasing ...
When a robust man suddenly drops dead and the newspapers report “heart failure,” the probability is that he died during an attack of angina pectoris. If he had gone to his doctor the day before, the ...
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Angina Pectoris Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global landscape of angina pectoris drugs is ...
Advances in pharmacotherapy for stable angina have produced a wide choice of drugs with various mechanisms of action, potentially enabling individualized, patient-specific treatment strategies to be ...
Background: There is speculation that women and South Asian people are more likely than men and white people to report atypical angina and that they are less likely to undergo invasive management of ...
The global angina pectoris drugs market is poised for substantial growth over the next decade, driven by a combination of rising cardiovascular disease incidence, advances in drug delivery ...
THE usefulness of cobra venom for the control of pain was first suggested in 1929 by Monaelesser. 1 In 1936, Bullrich 2 reported favorable results in the treatment of angina pectoris. Seven patients — ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results